Status
Conditions
Treatments
About
Study to evaluate the rate of clinically relevant complications associated with iStent inject placement in the post-market setting.
Full description
To evaluate the rate of clinically relevant complications associated with iStent inject placement and stability, as determined at 36 months in the postmarket setting.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Male or female ≥ 22 years of age
Mild to moderate primary open-angle glaucoma
Scheduled to undergo cataract surgery
Able and willing to attend scheduled follow-up exams for three years postoperatively
Able and willing to provide written informed consent on the IRB approved Informed Consent Form
Operative Inclusion Criterion:
Successful, uncomplicated cataract surgery
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
358 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal